Skip to main content
GRI logo
GRI
(NASDAQ)
GRI Bio, Inc.
$2.14-- (--)
Loading... - Market loading

GRI Bio (GRI) Stock Price & Financial Analysis

GRI Bio Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.03 - $2.16
52-Week High$64.12
52-Week Low$1.13
Open$2.14
Volume22.25K
Average Volume (3M)126.74K
Market Cap199.27M
Shares Outstanding98.16M
Price to Sales (P/S)6.90
Price to Book (P/B)33.17
EV/EBITDA-16.52
Revenue (TTM)28.87M
Net Income (TTM)-12.27M
Free Cash Flow (TTM)-11.16M
EPS (TTM)$-0.52
Profit Margin-42.50%
Operating Margin-42.57%
Return on Equity (ROE)-204.21%
Debt to Equity0.01
50-Day MA$2.42
200-Day MA$11.37
52-Week Change45.81%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About GRI Bio

What is the current stock price for GRI?

As of the latest trading session, GRI stock trades at $2.03. The 52-week range is $1.13–$64.12, with a day range of $2.03–$2.16.

What is the P/E ratio for GRI?

The P/E ratio (Price-to-Earnings) for GRI is shown in the Key Statistics section. This valuation metric helps compare GRI Bio, Inc. to industry peers.

Does GRI pay dividends?

GRI Bio does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for GRI?

Based on 1 analyst, the consensus for GRI is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of GRI?

GRI Bio's market capitalization is $199.3M, classifying it as a micro-cap company. GRI Bio operates in the Healthcare sector within the Biotechnology industry.